Vascular function in obese children with non-alcoholic fatty liver disease. 2011

Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
Division of Clinical Nutrition, Department of Pediatrics, Medical University Vienna, Austria.

OBJECTIVE To test whether obese children with non-alcoholic fatty liver disease have impaired vascular function compared with obese children with normal liver fat content. METHODS Obese children (n = 28, 16 males, mean age 10.9 ± 0.7 years, body mass index [BMI] 31.9 ± 4.5 kg/m(2)) with normal (HCLn) and increased hepatocellular lipid content (HCLi, 2.6 ± 0.8 vs. 12.4 ± 8.2%) were recruited, outcome measures being flow-mediated dilation of the brachial artery [FMD] measured by ultrasound, biochemical markers of inflammation (hs-CRP, hs-IL6) and cell adhesion molecules [CAMs], hepatocellular lipids, visceral and subcutaneous fat quantified by nuclear magnetic resonance spectroscopy and imaging. RESULTS HCLi and HCLn groups showed no significant differences in terms of age, gender, BMI, waist circumference and subcutaneous fat. Subjects in the HCLi group had significantly higher amounts of visceral fat and higher fasting glucose, insulin and triglyceride, but lower adiponectin levels and were more insulin resistant than their HCLn controls. Hepatic fat fraction (HFF) correlated positively with fasting plasma glucose, HOMA-IR, adiponectin, visceral fat, negatively with WBISI independent of BMI. HFF was not associated with subcutaneous fat, fasting insulin, FFA, HDL-C, TG, hs-CRP, hs-IL6, vCAM, iCAM, and FMD. HCLi patients had significantly higher serum levels of hs-CRP and hs-IL6 than HCLn controls. FMD and serum levels of vCAM and iCAM were comparable between groups. CONCLUSIONS Obese children with simple steatosis rather than steatohepatitis seem to have intact vascular function. Further studies in obese children with different grades of NAFLD are warranted to elucidate the role of fatty liver as a marker of risk for future cardiovascular events.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses

Related Publications

Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
September 2014, Journal of clinical research in pediatric endocrinology,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
October 2020, Hong Kong medical journal = Xianggang yi xue za zhi,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
July 2007, European journal of clinical nutrition,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
April 2013, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
January 2012, Journal of pediatric endocrinology & metabolism : JPEM,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
July 2013, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
June 2015, Pediatric obesity,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
June 2008, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
October 2011, World journal of gastroenterology,
Daniel Weghuber, and Michael Roden, and Carlo Franz, and Marek Chmelik, and Sherin Torabia, and Peter Nowotny, and Stephan Gruber, and Werner Waldhäusl, and Anton Klingler, and Christian Bieglmayer, and Martin Bischof, and Michael Wolzt, and Georg Schaller, and Kurt Widhalm
January 2009, Hormone research,
Copied contents to your clipboard!